MAPK3 and neoplasm: (85) found that CRAF overexpression to increased ERK1/2 level indicating some BRAF mutant tumor cells were primary insensitive to RAF inhibition in the experiment, which was related to a switch from BRAF to CRAF dependency in tumor cells.